Comparison of BCG vaccination at birth and at third month of life.

Evalution of Tuberculin Skin Test Four Months after BCG Vaccination at Birth

EVALUATION OF BCG IMMUNIZATION WITHIN THE FIRST 60 DAYS OF LIFE

The purpose of this study was to evaluate the efficacy ofthe BCG vaccine in the fIrst 60 days of life in inducing delayed-type hypersensitivity (DTH), and to evaluate the reliability of the Mantoux test in comparison with the BCG test for detecting DTH. A study was done in 885 healthy, well nourished infants 5 to 7 months old from rural areas of the Urumieh province, who received BCG immun...

BCG coverage and barriers to BCG vaccination in Guinea-Bissau: an observational study

BACKGROUND BCG vaccination is recommended at birth in low-income countries, but vaccination is often delayed. Often 20-dose vials of BCG are not opened unless at least ten children are present for vaccination ("restricted vial-opening policy"). BCG coverage is usually reported as 12-month coverage, not disclosing the delay in vaccination. Several studies show that BCG at birth lowers neonatal m...

Post-Vaccination disseminated BCG infection in an 8-month-old infant

Background: Disseminated bacilli calmette-Guerin (BCG) infection after inoculation with live vaccine is considered to result from impaired immunity of the child. However, half of the cases are regarded as idiopathic because no well-defined immunodeficiency condition can account for the infection. Case report: An 8-month-old male infant was admitted with an ulcer on his left arm at the site ...

ارزیابی میزان تأثیر واکسیناسیون B.C.G در دوره نوزادی

BCG vaccine has been used since 1921 for primary prevention of tuberculosis in man. The immunogenic efficacy of this vaccine has been reported between 2 to 83/. in various studies. In order to assess the efficacy of neonatal BCG vaccination in 200 infants who had received BCG vecctne at birth, BCG vaccine scars were measured and PPD test (5 unit strength) was performed at 3 months of age. The s...